Add Dixon Technologies Ltd For Target Rs. 4213 - Yes Securities
Growth and margin improvement priced in; downgrade to REDUCE
Result Synopsis
Revenue growth has been below expectation as consumer electronics segment saw flattish revenue growth which was marred by steep correction in open cell prices. In volume terms television has grown by 54%. Dixon fared better on margin front as margin in television improved on back of ODM solutions provided by the company saw higher traction. Q2 has seen continuing strong ramp?up in washing machines. Dixon has added capacities across the product categories as order book continues to remain strong. Dixon is expected to continue its strong growth momentum in medium term as 1) Order book across the categories continues to remain healthy; 2) New capacities have started commercial production; 3) Revenues from new product categories like wearables and refrigerators will drive incremental growth and; 4) New JV in, Wearables and Telecom products will add further growth levers. 5) Lighting exports has started in Q1 with order from UAE and soon will start exporting to US. Considering strong growth opportunities, we continue with our neutral stance as valuations continue to be rich and balance sheet has seen some deterioration as company is getting into new business verticals and expanding existing capacities. We continue to value company at 50x FY24 EPS
Despite near term uncertainties, Dixon is expected to deliver strong revenue growth in medium term given its strong order book, customer addition and capacities in place. We build?in FY22? 24E Revenue/EBITDA/PAT CAGR of 41%/53%/62%, we have marginally increased our EPS estimates on better margin profile resulting out of change in business mix and arrive at a PT of Rs4,213 valuing the company at 50x FY24 EPS. We however downgrade the stock to Reduce as there is downside from CMP
Result Highlights
Quarter summary – Dixon delivered lower than expected growth as its key category of television saw decline on yoy basis on back of sharp contraction in open cell prices which is 65% OF BOM. Other segments have registered strong growth
Margin – Gross margins contracted 35bps yoy. Dixon has been able to pass on increased commodity inflation in both its prescriptive and ODM business. EBITDA margin was largely in line with estimates
Order Book – Dixon continues to have a healthy order book position across existing business verticals which will enable it to accelerate growth momentum going forward. New customer additions and commercialization of expanded capacities will further give fillip to the order book.
Capacity expansion – Dixon continues to efficiently manage its working capital. It is expected to incur capex of Rs3.2bn in FY23 for opportunities in various PLI schemes apart from expanding capacities in its existing business
To Read Complete Report & Disclaimer Click Here
Please refer disclaimer at https://yesinvest.in/privacy_policy_disclaimers
SEBI Registration number is INZ000185632
Above views are of the author and not of the website kindly read disclaimer